Phase
Condition
Sexually Transmitted Diseases (Stds)
Gynecological Infections
Vaginal Atrophy
Treatment
Metronidazole Oral
Dequalinium Chloride
Clinical Study ID
Ages > 18 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Premenopausal woman ≥18 years
Diagnosis of bacterial vaginosis (all 4 Amsel criteria positive, i.e. 1) greyishwhite thin discharge, 2) postassium hydroxide (KOH) test or 'fishy' smell, 3)microscopic presence of > 20% clue cells, 4) vaginal pH > 4.5)
Signed Written Informed Consent to participate in this study
Exclusion
Exclusion Criteria:
Pregnancy and/or lactation based on urine Pregnancy test (women with childbearingpotential should use any contraception excluding vaginal methods like vaginal ring,etc.)
Uterine bleeding (including menstruation) or vaginal bleeding of unknown origin
Ulcerations/erosions of vaginal mucosa or cervix uteri
Patients with clinical symptoms and findings of Candida vulvovaginitis and/orAerobic vaginitis
Clinically manifest or suspicion of sexually transmitted infections (Neisseriagonorrhoeae, Chlamydia trachomatis, or Trichomonas vaginalis) based on signs,symptoms, and anamnesis
Use of any antimicrobial treatment (local or systemic) 14 days before entry thestudy
Use of any vaginal medication or vaginal douching 7 days before entry the study
Unwillingness to refrain from alcohol consumption during treatment, and 48 hoursafter treatment
Severe systemic diseases (HIV, cancer, tuberculosis, autoimmune diseases, diabetesmellitus, severe psychiatric conditions, etc.), including diseases treated withimmunosuppressive therapies, systemic corticosteroids, or warfarin
Known or suspected hypersensitivity to one of the study medications, inclusive oftheir excipients
Inability to follow the procedures of the study, e.g. due to language problems,psychological disorders, dementia, etc. of the participant (including inability tofill-in electronic patient diary)
Participation of patient in another investigational drug study concomitantly orwithin 30 days prior to entry in the study
Patient is relative of, or staff directly reporting to, the investigator
Study Design
Study Description
Connect with a study center
Centrum ambulantní gynekologie a primární péče, s.r.o.
Brno, 602 00
CzechiaSite Not Available
G-CENTRUM Olomouc s.r.o.
Olomouc, 772 00
CzechiaSite Not Available
GYNEKO spol. s r.o
Vsetín, 775 01
CzechiaSite Not Available
Gynekologicko-porodnická ambulance
Ústí nad Labem, 400 01
CzechiaSite Not Available
1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ
Lublin,
PolandSite Not Available
KO-MED CENTRA KLINICZNE Sp. z o.o. Ośrodek
Lublin,
PolandSite Not Available
NZOZ All-Med Centrum Medyczne
Łódź,
PolandSite Not Available
Salve Medica Sp. z o. o. S. K.
Łódź, 91-211
PolandSite Not Available
Prywatny Gabinet Ginekologiczno-Położniczy
Żurawica, 37-710
PolandSite Not Available
GPN, s.r.o.
Bratislava,
SlovakiaSite Not Available
RADMA GYN s.r.o.
Bratislava,
SlovakiaSite Not Available
MCM GYNPED s.r.o.
Dubnica Nad Váhom,
SlovakiaSite Not Available
GYNEDUR s.r.o
Dubnica nad Vahom,
SlovakiaSite Not Available
GYNECARE s.r.o.
Puchov,
SlovakiaSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.